Quantcast
Last updated on April 18, 2014 at 9:22 EDT

Latest Topiramate Stories

2014-04-15 23:16:16

A pharmaceutical product liability litigation firm, Carey Danis & Lowe announced that they have launched an investigation into alleged Topamax related injuries following news that a Philadelphia court has settled 76 Topamax cases. St. Louis, Missouri (PRWEB) April 15, 2014 Carey Danis & Lowe has launched an investigation into alleged Topamax related injuries, specifically those pertaining to alleged congenital birth defects. The announcement of the law firm's investigation...

2014-04-02 23:30:03

Flood Law Group today announced that they are available to investigate claims of birth defects such as cleft palates or cleft lips that could be related to the use of the prescription drug Topamax during pregnancy. The FDA issued a Drug Safety Communication about use of topiramate (the generic version of Topamax) in 2011. Washington, D.C. (PRWEB) April 02, 2014 Flood Law Group announced today that they are now actively investigating claims on behalf of parents whose children were born...

2014-03-14 12:28:58

Matthews & Associates says manufacturer ignored red flags about drug's dangers PHILADELPHIA, March 14, 2014 /PRNewswire/ -- A Houston-based plaintiffs firm specializing in drug injury law, Matthews & Associates, won a $3 million jury verdict in Philadelphia district court on March 7 for the family of a 5-year-old girl who suffered a severe cleft lip and cleft palate as a result of Topamax. After three weeks of testimony and four days of deliberation, 12 jurors found that drug...

2014-03-12 12:29:03

Qudexy(TM) XR Offers Newest Option for Managing Certain Seizure Disorders and Marks the Company's Entrance into the Epilepsy Therapeutic Area MAPLE GROVE, Minn., March 12, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced it received approval on March 11, 2014 from the U.S. Food and Drug Administration (FDA) for Qudexy(TM) XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth...

2014-03-11 23:02:05

Last week a Philadelphia jury awarded $3 million in damages to the family of a 5 year-old who suffered birth defects allegedly caused by the mother's ingestion of Topamax during pregnancy. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Topamax side effects. San Diego, CA (PRWEB) March 11, 2014 AttorneyOne.com, a recognized authority on...

2014-03-10 08:29:31

Court Finds Janssen Pharmaceuticals' Drug Topamax Caused Child's Cleft Palate ALTON, Ill., March 10, 2014 /PRNewswire/ -- A jury last week awarded a $3 million verdict to the family of a 5-year-old child born with bilateral cleft palate and lip as a result of the mother taking Topamax during pregnancy. Simmons Browder Gianaris Angelides & Barnerd LLC, a national complex litigation firm, represented parents Kelly and Brian Anderson against drug manufacturer Janssen...

2014-01-07 23:00:19

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) January 07, 2014 The prescription drug safety advocates at DrugNews.net have launched a 2014 Topamax Center for parents who took the antiepileptic drug while pregnant. The site has compiled research on the drug’s side effects, as well as safety alerts for patients, and legal news for claims alleging birth...

2014-01-01 23:02:14

Aid in Recovery, a full service drug and alcohol treatment center for substance abuse in South Florida, released a statement today commenting on new research that suggests that the seizure drug Topiramate is effective at treating cocaine and alcohol addiction. The study was conducted by scientists attached to prestigious universities in Virginia, Chicago, Baltimore and Texas. west palm beach florida (PRWEB) January 01, 2014 Aid in Recovery released a statement today commenting on a new...

2013-12-19 23:32:23

A national law firm providing pharmaceutical litigation services, Carey Danis & Lowe shares their expert legal opinion on the future of Topamax cases. St. Louis, Missouri (PRWEB) December 19, 2013 The personal injury litigation firm, Carey Danis & Lowe, represents those who have been harmed by defective drugs, and imparts their thoughts on the future of certain defective drug cases in light of the recent verdict in a Philadelphia court hearing a Topamax case known as Gurley v....

2013-12-10 08:31:19

Impact of Delayed-Dose Administration Results also Announced at the American Epilepsy Society Annual Meeting MAPLE GROVE, Minn., Dec. 10, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the presentation of new Phase 1 data showing that USL255 (extended-release topiramate) may provide a beneficial treatment option for individuals with difficulty swallowing whole capsules or tablets. Additionally, simulations of data from another Phase 1 study...